Investigational Site Number : 6420006

Brasov 500450

0 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Type 2 Diabetes Mellitus

Studies at this site

• Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period — Completed